Google's life sciences arm, Verily, has released 32 million sterile male mosquitoes to curb mosquito-borne diseases.
The initiative aims to reduce mosquito populations without increasing biting risks, as male mosquitoes do not bite.
Google's life sciences arm, Verily, has released 32 million sterile male mosquitoes to curb mosquito-borne diseases.
The initiative aims to reduce mosquito populations without increasing biting risks, as male mosquitoes do not bite.

AI-generated illustration · NewsDarpan (GPT-Image-2)
In a groundbreaking initiative to combat mosquito-borne diseases such as dengue and malaria, Google's life sciences division, Verily, has released 32 million sterile male mosquitoes. The innovative project, which focuses on reducing mosquito populations through controlled biological intervention, ensures that these males do not contribute to the biting population, as only female mosquitoes bite.
The approach involves releasing male mosquitoes that have been sterilized using advanced scientific methods. When these sterile males mate with wild females, the resulting eggs fail to hatch, gradually reducing the mosquito population in the targeted areas. This method is considered a safer and more environmentally friendly alternative to chemical pesticides, which often have adverse effects on ecosystems.
Verily's initiative is part of a broader effort to tackle the growing threat of mosquito-borne illnesses, which affect millions of people annually in tropical and subtropical regions, including India. By focusing on male mosquitoes, the project avoids increasing the number of biting insects, addressing a common concern with mosquito control programs.
The release of 32 million mosquitoes marks a significant step in leveraging technology and science to address public health challenges. While the long-term impact of this initiative remains to be seen, it has already sparked interest and optimism among researchers and public health experts worldwide.